Where to inject tesamorelin?

Tesamorelin is FDA approved as Egrifta, a daily shot under the skin for people with HIV who have abnormal fat buildup (lipodystrophy). That product's own label, not this page, names the spots and the steps. This FAQ does not reprint a dose, a frequency, or a protocol. A research-chemical vial sold as tesamorelin is not Egrifta. For a research vial given under the skin, the body is the same, with the same four spots, and you should rotate them. How to inject is at /injecting. Profile at /compounds/tesamorelin.

Full injecting guide: sites, needles, rotation, safety

Educational use only. This database summarizes published research and is not medical advice. Where a dose appears it is a record of what a trial or clinic ran, or what people describe doing, with its source attached. Nothing here is a recommendation for personal use.

Part of injecting: sites, needles and safety. Subcutaneous vs intramuscular, site rotation, lipohypertrophy, needle length and gauge, vial hygiene at injection time, travel syringes, scar tissue, and when to stop and see a clinician. Full walkthrough at /injecting.